Legend Biotech Corp. (LEGN)
22.11
-0.21
(-0.94%)
USD |
NASDAQ |
Dec 15, 13:51
Legend Biotech Total Assets (Quarterly): 1.713B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CorMedix, Inc. | 750.86M |
| Exelixis, Inc. | 2.824B |
| Abeona Therapeutics, Inc. | 231.10M |
| Akero Therapeutics, Inc. | 1.006B |
| Cabaletta Bio, Inc. | 189.76M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 693.56M |
| Shareholders Equity (Quarterly) | 1.011B |
| Debt to Equity Ratio | 0.4057 |
| Current Ratio | 2.865 |
| Net Debt Paydown Yield | -0.24% |